PureTech Health Stock Target Price and Analyst Consensus
| PRTC Stock | USD 18.55 1.12 5.69% |
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize PureTech Health price targets
PureTech Health's stock target price is an estimate of its future price, usually made by analysts. Using PureTech Health's target price to determine if it is a suitable investment can be done through the following steps:- Look at PureTech Health's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if PureTech Health's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional PureTech Health Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of PureTech Health is a key component of PureTech Health valuation and have some predictive power on the future returns of a PureTech Health.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PureTech Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Power Assets Invested over 90 shares | |
 | Petroleum and Natural Gas Invested over 90 shares | |
 | Communication Invested over 90 shares | |
 | Information Technology ETFs Invested over 90 shares | |
 | Macroaxis Index Invested over 90 shares | |
 | Banks Invested over 90 shares | |
 | Giant Impact Invested few shares | |
 | Measuring and Control Equipment Invested few shares | |
 | Steel Works Etc Invested over 90 shares | |
 | Robots And Drones Invested a lot of shares |
Check out Macroaxis Advice on PureTech Health to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Please note, the presentation of PureTech Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, PureTech Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of PureTech Health's management manipulating its earnings.